Invention Grant
- Patent Title: FLT3 receptor antagonists for the treatment or the prevention of pain disorders
-
Application No.: US14793823Application Date: 2015-07-08
-
Publication No.: US09765339B2Publication Date: 2017-09-19
- Inventor: Jean Valmier
- Applicant: Jean Valmier
- Applicant Address: FR Paris FR Montpellier
- Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),UNIVERSITE DE MONTPELLIER
- Current Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),UNIVERSITE DE MONTPELLIER
- Current Assignee Address: FR Paris FR Montpellier
- Agency: Whitham, Curtis & Cook
- Priority: EP10305013 20100105
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/02 ; C07H21/04 ; C12N15/11 ; C12N15/113 ; C12N15/115 ; A61K31/404 ; A61K31/553 ; C07K16/28 ; G01N33/50
Abstract:
The present invention relates to FLT3 receptor antagonists or inhibitors of FLT3 receptor gene expression for the treatment or the prevention of pain disorders.
Public/Granted literature
- US20150307887A1 FLT3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OR THE PREVENTION OF PAIN DISORDERS Public/Granted day:2015-10-29
Information query
